An evaluation of no-treatment decisions in patients with newly diagnosed acute myeloid leukemia

被引：2
|
作者：
Brandwein, Joseph M. [1 ]
Hallett, Darren [1 ]
Karkhaneh, Mohammad [2 ]
Zhu, Nancy [1 ]
Liew, Elena [1 ]
Bolster, Lauren [1 ]
Hamilton, Marlene [1 ]
Patterson, Jeffrey [1 ]
Taparia, Minakshi [1 ]
Wu, Cynthia [1 ]
Van Slyke, Tiffany [1 ]
Bankar, Aniket [1 ]
Saini, Lalit [3 ]
机构：
[1] Univ Alberta, Dept Med, Edmonton, AB, Canada
[2] Inst Hlth Econ, Edmonton, AB, Canada
[3] London Hlth Sci Ctr, Dept Med, London, ON, Canada
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2021年 / 96卷 / 01期
关键词：
OUTCOMES;
D O I：
10.1002/ajh.26012
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E17 / E20
页数：5
相关论文
共 50 条
  • [31] How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia
    Jonas, Brian A.
    Pollyea, Daniel A.
    LEUKEMIA, 2019, 33 (12) : 2795 - 2804
  • [32] Real world outcomes among patients with newly diagnosed acute myeloid leukemia
    Pulte, Elizabeth D.
    Fernandes, Laura L.
    Wynne, Joseph
    Hansen, Eric
    Belli, Andrew J.
    Barcellos, Anna
    Zettler, Christina M.
    Bystrom, Rebecca
    Vallejo, Jonathon
    Gu, Wenjuan
    Lerro, Catherine
    Norsworthy, Kelly
    DeClaro, Angelo
    Theoret, Marc R.
    Rivera, Donna
    Wang, Ching-Kun
    CANCER RESEARCH, 2024, 84 (06)
  • [33] Outcomes of patients with newly diagnosed acute myeloid leukemia (AML) and hyperleukocytosis.
    Haddad, Fadi
    Sasaki, Koji
    Abuasab, Tareq
    Venugopal, Sangeetha
    Rivera, Daniel
    Bazinet, Alexandre
    Babakhanlou, Rodrick
    Kim, Kunhwa
    Senapati, Jayastu
    Ong, Faustine
    Desikan, Sai Prasad
    Short, Nicholas James
    Pemmaraju, Naveen
    Borthakur, Gautam
    Dinardo, Courtney Denton
    Daver, Naval Guastad
    Jabbour, Elias
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Kadia, Tapan M.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E19029 - E19029
  • [34] The risk of early mortality in elderly patients with newly diagnosed acute myeloid leukemia
    Liu, Chia-Jen
    Hong, Ying-Chung
    Kuan, Ai Seon
    Yeh, Chiu-Mei
    Tsai, Chun-Kuang
    Liu, Yao-Chung
    Hsiao, Liang-Tsai
    Wang, Hao-Yuan
    Ko, Po-Shen
    Chen, Po-Min
    Liu, Jin-Hwang
    Gau, Jyh-Pyng
    CANCER MEDICINE, 2020, 9 (04): : 1572 - 1580
  • [35] Azacitidine and venetoclax with or without pevonedistat in patients with newly diagnosed acute myeloid leukemia
    Short, Nicholas J.
    Wierzbowska, Agnieszka
    Cluzeau, Thomas
    Laribi, Kamel
    Recher, Christian
    Czyz, Jaroslaw
    Ochrem, Bogdan
    Ades, Lionel
    Gallego-Hernanz, Maria Pilar
    Heiblig, Mael
    Audisio, Ernesta
    Zarzycka, Ewa
    Li, Shuli
    Ferenc, Nicholas
    Yeh, Tammie
    Faller, Douglas V.
    Sedarati, Farhad
    Papayannidis, Cristina
    LEUKEMIA & LYMPHOMA, 2025, 66 (03) : 458 - 468
  • [36] Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?
    Roellig, Christoph
    Kramer, Michael
    Schliemann, Christoph
    Mikesch, Jan-Henrik
    Steffen, Bjoern
    Kramer, Alwin
    Noppeney, Richard
    Schaefer-Eckart, Kerstin
    Krause, Stefan W.
    Haenel, Mathias
    Herbst, Regina
    Kunzmann, Volker
    Einsele, Hermann
    Jost, Edgar
    Bruemmendorf, Tim H.
    Scholl, Sebastian
    Hochhaus, Andreas
    Neubauer, Andreas
    Sohlbach, Kristina
    Fransecky, Lars
    Kaufmann, Martin
    Niemann, Dirk
    Schaich, Markus
    Frickhofen, Norbert
    Kiani, Alexander
    Heits, Frank
    Kruempelmann, Ulrich
    Kaiser, Ulrich
    Kullmer, Johannes
    Wass, Maxi
    Stoelzel, Friedrich
    von Bonin, Malte
    Middeke, Jan Moritz
    Thiede, Christian
    Schetelig, Johannes
    Berdel, Wolfgang E.
    Ehninger, Gerhard
    Baldus, Claudia D.
    Muller-Tidow, Carsten
    Platzbecker, Uwe
    Serve, Hubert
    Bornhaeuser, Martin
    BLOOD, 2020, 136 (07) : 823 - 830
  • [37] Cusatuzumab plus azacitidine in Japanese patients with newly diagnosed acute myeloid leukemia ineligible for intensive treatment
    Ikezoe, Takayuki
    Usuki, Kensuke
    Aida, Kensuke
    Hatayama, Tomoyoshi
    Shirahase, Toru
    Yamauchi, Takahiro
    CANCER SCIENCE, 2023, 114 (03) : 1037 - 1044
  • [38] Treatment With Leukapheresis In Patients Diagnosed With Hyperleukocytic Acute Myeloid Leukemia
    Martinez-Cuadron, David
    Montesinos, Pau
    Moscardo, Federico
    Lopez, Lineth
    Martin, Guillermo
    Solves, Pilar
    Boluda, Blanca
    Perez-Sirvent, Mariluz
    Vera, Belen
    Navarro, Ines
    Alonso, Carmen M.
    Martinez, Jesus
    Lopez-Chulia, Francisca
    Sanz, Jaime
    Carpio, Nelly
    Rodriguez-Veiga, Rebeca
    Iacoboni, Gloria
    Sanz, Guillermo
    Sanz, Miguel
    BLOOD, 2013, 122 (21)
  • [39] PROGNOSTIC FACTORS AND TREATMENT OUTCOME OF CHILDREN WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA.
    Zahra, K.
    Ben Sayed, N.
    Ben Youssef, Y.
    Zaier, M.
    Achour, B.
    Rgaieg, H.
    Khelif, A.
    HAEMATOLOGICA, 2014, 99 : 571 - 571
  • [40] Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date
    Iyer, Sunil Girish
    Stanchina, Michele
    Bradley, Terrence J.
    Watts, Justin
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2267 - 2272
12345